News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015
News Daily News CTOs Relatively Frequent in Patients Without Previously Known CAD Nicole Lou June 30, 2015
News Industry News New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets June 19, 2015
News Daily News In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries June 16, 2015
News Daily News Los Pacientes IAM de Alto Riesgo son Menos Propensos a Seguir Tratamientos Recomendados por las Directrices Tras el Alta Hospitalaria Yael L. Maxwell April 03, 2015
News Daily News High-Risk Acute MI Patients Less Likely to Stay on Guideline-Recommended Therapies After Hospital Discharge Yael L. Maxwell April 03, 2015
Presentation Longitudinal Persistence With Secondary Prevention Therapies Relative to Patient Risk After MI Presenter: Supriya Shore April 02, 2015
News Conference News ACC 2015 ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted Todd Neale March 20, 2015
News Daily News Heart Failure Still a Problem but Less of a Burden on Acute MI Patients Todd Neale March 11, 2015
News Industry News New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions February 24, 2015
News Daily News Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM L.A. McKeown February 22, 2015
News Daily News Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI L.A. McKeown February 22, 2015
News Daily News Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors Salynn Boyles December 11, 2014